Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm

Nucleos(t)ide analogues (NA) are widely used to treat hepatitis B virus (HBV) infection, but they cannot eradicate the virus and treatment duration can be lifelong if the endpoint is set at seroclearance of the hepatitis B surface antigen (HBsAg). As an alternative strategy, finite NA therapy withou...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Korean Association for the Study of the Liver 2023-10-01
Цуврал:	Clinical and Molecular Hepatology
Нөхцлүүд:	hepatitis b virus infection antiviral agents hepatitis b surface antigens patient safety
Онлайн хандалт:	http://e-cmh.org/upload/pdf/cmh-2022-0420.pdf
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!